Fluid & Electrolyte Balance, Transfusion Therapy and Acid–Base Review

Magnesium: Physiology & Sources

  • Second-most abundant intracellular cation after potassium.
  • 50\text{–}60\% of total body Mg is stored in bone; remainder in muscle & soft tissue.
  • Core functions
    • Regulates nerve impulse transmission & skeletal/ smooth/ cardiac muscle contraction.
    • Stabilises blood pressure & modulates vascular tone.
    • Participates in carbohydrate metabolism → maintains serum glucose.
    • Structural support for bone & teeth (with Ca & P).
    • Essential co-factor in >300 enzymatic reactions: protein, DNA & RNA synthesis.
  • Dietary acquisition
    • Whole foods: leafy greens (spinach, kale), nuts/seeds (almonds, cashews, pumpkin seeds), legumes (black beans, chick-peas, lentils), whole grains (quinoa, brown rice, oats, whole-wheat bread), fatty fish (salmon, mackerel), avocado, banana, dark chocolate \ge 70\% cocoa.
    • Fortified products: breakfast cereals, plant milks (almond, soy), selected breads & snack bars.
    • Supplements (Mg oxide, citrate, glycinate, etc.) if ordered.

Normal & Critical Serum Mg Values

  • Reference laboratory range (adult): 1.6\text{–}2.6\,\text{mg·dL}^{-1} (facility specific).
  • Critical
    • Severe hypomagnesaemia < 0.5\,\text{mg·dL}^{-1}.
    • Severe hypermagnesaemia > 3.0\,\text{mg·dL}^{-1} (life-threatening threshold rises to >12\,\text{mg·dL}^{-1}).

Hypomagnesaemia

  • Aetiology
    • Medication losses: loop & thiazide diuretics, certain aminoglycosides, proton-pump inhibitors.
    • ↓ Intake: poor diet, general under-nutrition.
    • ↓ GI absorption: Crohn’s, coeliac disease.
    • ↑ GI losses: severe diarrhoea, pancreatitis.
    • ↑ Renal excretion: uncontrolled T2DM (osmotic diuresis), alcohol use disorder, post-burn diuresis.
    • Associated electrolyte shifts: hypokalaemia, hypocalcaemia.
  • Clinical presentation (usually at <1.2\,\text{mg·dL}^{-1})
    • Mild–moderate: nausea, vomiting, anorexia, fatigue, generalised weakness.
    • Severe: neuromuscular irritability (tetany, cramps, spasticity), paraesthesias, seizures, personality/ mood change, arrhythmias & coronary/ peripheral vasospasm— potentiated when combined with other dyselectrolytaemias.
  • Diagnostics
    • Serum Mg on BMP/CMP; always assess concurrent K^+ & Ca^{2+}.
    • 12-lead ECG for dysrhythmia.
  • Management
    • Oral Mg salts for mild–moderate deficit (observe for diarrhoea).
    • IV Mg sulfate for severe or symptomatic cases (telemetry required).
    • Correct underlying cause; reinforce Mg-rich diet.

Hypermagnesaemia

  • Criticality scale
    • Moderate symptoms above 7\,\text{mg·dL}^{-1}.
    • Severe/ life-threatening at >12\,\text{mg·dL}^{-1}.
  • Causes
    • Renal insufficiency/ failure (most common: impaired excretion).
    • Excess intake: Mg-containing laxatives, antacids, over-supplementation.
    • Drug-induced: lithium, chronic opioids.
    • Massive tissue injury/ trauma (cellular release).
  • Symptom progression
    1. Mild – nausea, dizziness, lethargy, confusion.
    2. Moderate – worsening confusion, somnolence, blurred vision, headache, flushing, constipation.
    3. Severe – flaccid paralysis, respiratory depression, profound hypotension, bradycardia → AV block, seizure, coma, cardiac arrest.
  • Work-up mirrors hypomagnesaemia (BMP/CMP ± ECG).
  • Treatment
    • Mild: discontinue Mg sources (OTC antacids/ laxatives/supplements).
    • Moderate: IV Ca^{2+} (gluconate or chloride) as physiological antagonist; IV loop diuretics + isotonic saline to enhance renal excretion.
    • Severe/ anuric renal failure: emergent haemodialysis.
    • Continuous monitoring of cardiac rhythm, BP, neuromuscular status; serial Mg labs.

Dehydration (Water Loss > Sodium Loss)

  • Definition: Pure H₂O deficit → hypernatraemia & ↑ plasma osmolality.
  • Contributing factors
    • GI fluid loss (vomiting, diarrhoea).
    • Excessive perspiration (fever, heat exposure).
    • Polyuria (e.g., uncontrolled DM, diuretics).
    • Fever, ↓ fluid intake, impaired thirst (elderly, infants, benzodiazepines, SSRIs).
  • Manifestations
    • Mild–moderate: thirst, dry mucosa, lethargy, cognitive slowing, ↓ skin turgor, oliguria (concentrated urine).
    • Severe: tachycardia, hypotension (↓ preload), shock, coma → multi-organ failure if uncorrected.
  • Diagnostics: BMP/CMP (hypernatraemia), ↑ serum osmolality, urine specific gravity >1.030.
  • Therapy
    • Oral rehydration solutions if alert.
    • IV hypotonic: D5W or 0.45\% NS, infused slowly to prevent cerebral oedema.

Fluid Volume Deficit: Hypovolaemia

  • Loss of both water & electrolytes → ↓ circulating volume.
  • Aetiology: haemorrhage, diarrhoea/ vomiting, severe burns (capillary leak), third-spacing (ascites, pancreatitis), excessive sweating, over-diuresis, major trauma.
  • S/S (progressive)
    • Early: thirst, dry mucous membranes, tenting skin (unreliable in elderly), ↓ urine output.
    • Progression: lethargy, muscle weakness, orthostatic hypotension, tachycardia (compensatory).
    • Severe: confusion, tachypnoea, chest pain, palpitations, oliguria, hypovolaemic shock (>20\% blood volume loss) → MODS.
  • Diagnostics
    • BMP/CMP: dyselectrolytaemias.
    • ↑ BUN/Cr (prerenal); CBC may show ↑ haemato­crit (hemoconcentration) or ↓ if haemorrhage.
    • Urine specific gravity high.
  • Treatment
    • Mild: oral fluids/electrolytes.
    • Moderate–severe: isotonic IV 0.9\% NS or Lactated Ringer’s; PRBC transfusion if haemorrhagic.

Fluid Volume Excess: Hypervolaemia

  • Excess Na^+ & H₂O in ECF.
  • Common causes: CHF (↓ cardiac output → RAAS activation), CKD (↓ urine output), cirrhosis/ ESLD (portal HTN, ↓ albumin → ascites), drugs (vasodilators, CCBs).
  • Hallmark findings
    • Rapid weight gain, peripheral/ sacral oedema.
    • Cardiopulmonary: JVD, bounding pulse, hypertension, crackles/ rales, dyspnoea; severe → pulmonary oedema & respiratory distress.
  • Work-up: Daily weights, oedema grading, BMP/CMP (variable Na^+), urine Na^+ to assess renal handling.
  • Management
    • Loop diuretics (furosemide); thiazides if mild.
    • Fluid & sodium restriction.
    • Daily weights, I&O charting.
    • Haemodialysis in refractory CKD; paracentesis for tense ascites.

Blood Components & Their Uses

  • Whole blood seldom transfused—components are targeted via centrifugation (≈60\% plasma / 40\% cells).
  • Red Blood Cells (PRBC)
    • Carry O2 & remove CO2; lifespan 120 days; production \approx2\times10^6 cells·s^{-1}.
    • 1 unit PRBC raises Hb by \approx1\,\text{g·dL}^{-1} & Hct by 3\%.
    • Typical trigger: Hb < 7\text{–}8\,\text{g·dL}^{-1} (patient/context dependent).
    • Rough rule: Hct \approx Hb \times 3 (e.g., Hb 10\Rightarrow Hct\sim30\%).
  • Platelets
    • Indicated when count < 20{,}000\,\text{µL}^{-1} or active bleeding.
    • Single transfusion may pool platelets from up to 10 donors.
  • Plasma (FFP)
    • Contains clotting factors, proteins, electrolytes; stored frozen & thawed → Fresh Frozen Plasma.
    • Utilised for coagulopathy, massive transfusion, liver failure, burns.
    • Fractionation yields derivatives (albumin, factor VIII, immunoglobulin, etc.).
  • Cryoprecipitate: rich in fibrinogen, factor VIII, XIII & vWF.
  • Granulocytes (WBC) rarely transfused—reserved for severe neutropenia unresponsive to G-CSF.
  • Autologous donation: patient pre-donates own blood for elective surgery; NOT acceptable to most Jehovah’s Witnesses.

ABO & Rh Blood Grouping

  • Four ABO phenotypes: A, B, AB, O — determined by surface antigens.
  • Rh factor: D antigen present (Rh+) or absent (Rh-).
  • Incompatible transfusion → immune-mediated haemolysis (life-threatening).
  • Compatibility ensured by:
    • Type & screen (ABO/Rh).
    • Cross-match: recipient plasma + donor RBC; agglutination = incompatible.
    • Plasma & platelets require ABO/Rh typing but not formal cross-match.

Transfusion Procedure & Safety Checklist

  1. Obtain informed consent & baseline vitals.
  2. Large-bore IV (18\text{–}20 G) patent; gather Y-tubing, 0.9\% NS only.
  3. Retrieve blood—must begin within 30 min & complete within \le4 h.
  4. Two RNs verify at bedside: patient ID, unit number, ABO/Rh, expiration.
  5. Remain with patient first 15 min; repeat vitals at 15 min, facility protocol, end of transfusion & +1 h.

Acute Transfusion Reactions (within 24 h)

  • Acute haemolytic (ABO incompatible): fever, chills, flank pain, haemoglobinuria → DIC, renal failure.
  • Febrile non-haemolytic: temp rise >1\,^{\circ}\text{C} from donor WBC cytokines.
  • Allergic: urticaria → anaphylaxis.
  • TRALI: non-cardiogenic pulmonary oedema.
  • TACO: circulatory overload from rapid infusion.

Immediate Nursing Actions

  • STOP transfusion, keep IV line with 0.9\% NS.
  • Re-check identifiers, notify provider & blood bank.
  • Send blood bag, tubing, patient blood & urine to lab.
  • Supportive care: O₂, fluids, meds as ordered.

Delayed Transfusion Reactions ( >24 h – weeks)

  • Delayed haemolytic TR: mild, often unnoticed.
  • TA-GVHD: donor T-cells attack host; usually fatal.

Acid–Base Balance Essentials

  • pH = “power of H^+”.
    • Normal arterial range 7.35\text{–}7.45.
  • Homeostatic controls
    1. Chemical buffers (instant): bicarbonate, phosphate, proteins.
    2. Respiratory (minutes, transient): adjust CO_2 via rate/depth.
    • ↑ RR → ↓ CO_2 → ↓ H^+ (alkalinises).
    • ↓ RR → ↑ CO_2 → ↑ H^+ (acidifies).
    1. Renal (hours–days, powerful): reabsorb/ excrete HCO_3^- & H^+.
  • Renal impairment => high risk of uncorrected acidosis/ alkalosis.

Arterial Blood Gas (ABG) Parameters

  • pH : acid–base status.
  • PaCO_2 (35–45 mmHg): respiratory component.
  • HCO_3^- (22–26 mEq·L^{-1}): metabolic component.
  • PaO2 (80–100 mmHg) & SaO2 (95–100 %) assess oxygenation.
  • Disorders named by primary cause
    • Respiratory acidosis/ alkalosis \Rightarrow driven by PaCO_2.
    • Metabolic acidosis/ alkalosis \Rightarrow driven by HCO_3^-.

(NB: Full ABG interpretation is mastered in Med-Surg.)

Self-Study — Intravenous Therapy (Required Reading)

  • Calculate IV flow rates & titration.
  • Principles of rehydration therapy.
  • Selecting, initiating & maintaining IV tubing/ infusion pumps.
  • Peripheral vs central venous access devices.
  • Recognition & management of IV-related complications (infiltration, phlebitis, CLABSI, air embolus, catheter occlusion).